Compare CTKB & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTKB | AVNS |
|---|---|---|
| Founded | 1990 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 582.3M | 659.5M |
| IPO Year | 2021 | 2014 |
| Metric | CTKB | AVNS |
|---|---|---|
| Price | $4.67 | $24.63 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.63 | N/A |
| AVG Volume (30 Days) | 548.8K | ★ 957.8K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.59 |
| EPS | ★ N/A | N/A |
| Revenue | $193,015,000.00 | ★ $701,200,000.00 |
| Revenue This Year | $5.42 | $3.28 |
| Revenue Next Year | $7.03 | $4.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.67 | 1.95 |
| 52 Week Low | $2.37 | $9.30 |
| 52 Week High | $6.18 | $24.70 |
| Indicator | CTKB | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 57.30 | 92.26 |
| Support Level | $4.56 | $10.94 |
| Resistance Level | $4.85 | N/A |
| Average True Range (ATR) | 0.18 | 0.35 |
| MACD | 0.02 | 1.11 |
| Stochastic Oscillator | 69.70 | 99.47 |
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.